Literature DB >> 25445134

Antiplatelet therapy: risks and benefits of extended DAPT after stenting.

Karina Huynh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25445134     DOI： 10.1038/nrcardio.2014.192

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  4 in total

1.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Authors:  Robert W Yeh; Matthew J Czarny; Sharon-Lise T Normand; Dean J Kereiakes; David R Holmes; Ralph G Brindis; W Douglas Weaver; John S Rumsfeld; Matthew T Roe; Sunghee Kim; Priscilla Driscoll-Shempp; Laura Mauri
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-11-16

3.  Dual antiplatelet therapy after drug-eluting stents--how long to treat?

Authors:  Antonio Colombo; Alaide Chieffo
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

Review 4.  Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Authors:  Sammy Elmariah; Laura Mauri; Gheorghe Doros; Benjamin Z Galper; Kelly E O'Neill; Philippe Gabriel Steg; Dean J Kereiakes; Robert W Yeh
Journal:  Lancet       Date:  2014-11-16       Impact factor: 79.321
  4 in total
  1 in total

Review 1.  Drug-eluting coronary stents: insights from preclinical and pathology studies.

Authors:  Sho Torii; Hiroyuki Jinnouchi; Atsushi Sakamoto; Matthew Kutyna; Anne Cornelissen; Salome Kuntz; Liang Guo; Hiroyoshi Mori; Emanuel Harari; Ka Hyun Paek; Raquel Fernandez; Diljon Chahal; Maria E Romero; Frank D Kolodgie; Anuj Gupta; Renu Virmani; Aloke V Finn
Journal:  Nat Rev Cardiol       Date:  2019-07-25       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.